This segment focuses on the development, manufacturing, and distribution of over-the-counter healthcare products and wellness solutions. Research and development efforts are directed towards creating innovative formulations and delivery methods, such as oral soft gel capsules, thin film dissolvable strips, and topical creams, to enhance product efficacy and patient compliance. The division targets a broad range of health concerns, including pain management, sleep disorders, and gastrointestinal issues, with a focus on natural and alternative therapies. Market positioning emphasizes accessibility and affordability, catering to consumers seeking self-care solutions. Future opportunities include expanding the product portfolio with novel ingredients and formulations, leveraging e-commerce channels for direct-to-consumer sales, and establishing strategic partnerships with retailers and distributors.

This segment is dedicated to the research, development, and commercialization of prescription drugs and therapies targeting chronic diseases such as diabetes, cancer, and autoimmune disorders. Research and development activities encompass drug discovery, preclinical studies, and clinical trials to evaluate the safety and efficacy of novel drug candidates. The division employs advanced technologies such as transmucosal drug delivery systems to improve drug bioavailability and patient outcomes. Therapeutic areas of focus include oncology, endocrinology, and immunology, with a commitment to addressing unmet medical needs. Market positioning emphasizes scientific rigor, regulatory compliance, and strategic partnerships with healthcare providers and research institutions. Future opportunities include securing FDA approvals for innovative therapies, expanding the pipeline with targeted biologics and personalized medicine approaches, and establishing a strong presence in specialty pharmaceutical markets.